You are here

James Brice
Thoracic radiologists are at odds with one another about the benefits of image enhancement and analytical tools for low-dose CT lung cancer screening.
Small studies assessing the efficacy of coronary CT angiography (CCTA) to diagnose or rule out coronary artery disease (CAD) have been the staple reference standard for its adoption. But a new era of comparative-effectiveness research is unfolding as CCTA will be tested against other validated cardiac imaging modalities, in particular, SPECT myocardial perfusion imaging (MPI).
When a SPECT myocardial perfusion study of a patient with persistent angina produced a normal result, the attending cardiologist at the Medical University of South Carolina in Charleston suspected the study had missed something more serious.